NEW YORK (GenomeWeb News) — Third Wave Technologies today said fourth-quarter revenues increased 17 percent as R&D spending nearly doubled and net loss narrowed 8 percent.  
 
Total receipts for the three months ended Dec. 31, 2006, increased to $6.8 million from $5.8 million year over year.
 
Revenue from molecular diagnostics rose to $5.8 million from $4.3 million, but receipts from research products declined to $954,000 from $2.4 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.